Urine bactericidal activity of pefloxacin versus norfloxacin in healthy female volunteers after a single 800-mg oral dose

被引:13
作者
Hofbauer, H
Naber, KG
KinzigSchippers, M
Sorgel, F
RustigeWiedemann, C
Wiedemann, B
Reiz, A
Kresken, M
机构
[1] RHONE POULENC RORER GMBH,D-50829 COLOGNE,GERMANY
[2] KLINIKUM ST ELISABETH,UROL KLIN,D-94315 STRAUBING,GERMANY
[3] INST BIOMED & PHARMAZEUT FORSCH,D-90562 NURNBERG,GERMANY
[4] UNIV BONN,D-53115 BONN,GERMANY
关键词
D O I
10.1007/BF02113592
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
In an open randomised crossover study the antibacterial activity of pefloxacin and norfloxacin was assessed in the urine after a single 800-mg oral dose in 14 healthy female volunteers, Pefloxacin demonstrated lower peak concentrations in the urine than norfloxacin (mean, 217.2 mg/l versus 492.9 mg/l as determined by the microbiological assay) but pefloxacin was present over a longer period of time in sufficient concentrations than norfloxacin, Mean urine levels of at least 2 mg/l were present for 7 days after pefloxacin administration and 2 days after norfloxacin administration as determined by the microbiological assay, Overall, the urinary recovery of pefloxacin and norfloxacin amounted to 49.3% and 25.1%, respectively, of the total administered dose, The average urine bactericidal activity against the five test organisms was as follows: against reference strain Escherichia coli ATCC 25922 susceptible to nalidixic acid (Nal-S) for 5 days with pefloxacin and 2 days with norfloxacin; against three clinical isolates, one strain each of E, coli resistant to nalidixic acid (Nal-R), Klebsiella pneumoniae Nal-R, and Staphylococcus Saprophyticus, for 3 days with pefloxacin and 24 h with norfloxacin; and against a clinical isolate of Enterococcus faecalis for 2 days with pefloxacin and 12 h with norfloxacin, In conclusion, pefloxacin as a single dose proved to have sufficiently high and long-lasting urine bactericidal activity against urinary pathogens, These findings support the results of a meta-analysis of seven clinical trials in patients with uncomplicated lower Un, demonstrating a single oral dose of 800 mg pefloxacin to be as effective as a conventional treatment with comparative drugs [21].
引用
收藏
页码:121 / 126
页数:6
相关论文
共 21 条
[1]   INVITRO ACTIVITY OF NEWER QUINOLONES AGAINST AEROBIC-BACTERIA [J].
AUCKENTHALER, R ;
MICHEAHAMZEHPOUR, M ;
PECHERE, JC .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1986, 17 :29-39
[2]   INVITRO ACTIVITY OF CIPROFLOXACIN, NORFLOXACIN AND NALIDIXIC-ACID [J].
BAUERNFEIND, A ;
PETERMULLER, C .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1983, 2 (02) :111-115
[3]   PHARMACOKINETICS OF NORFLOXACIN IN HEALTHY-VOLUNTEERS AND PATIENTS WITH RENAL AND HEPATIC DAMAGE [J].
EANDI, M ;
VIANO, I ;
DINOLA, F ;
LEONE, L ;
GENAZZANI, E .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1983, 2 (03) :253-259
[4]   PEFLOXACIN - A REVIEW OF ITS ANTIBACTERIAL ACTIVITY, PHARMACOKINETIC PROPERTIES AND THERAPEUTIC USE [J].
GONZALEZ, JP ;
HENWOOD, JM .
DRUGS, 1989, 37 (05) :628-668
[5]  
GUIBERT J, 1989, PATHOL BIOL, V37, P406
[6]   EFFECT OF METHOD, MEDIUM, PH AND INOCULUM ON THE INVITRO ANTIBACTERIAL ACTIVITIES OF FLEROXACIN AND NORFLOXACIN [J].
HOHL, P ;
FELBER, AM .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1988, 22 :71-80
[7]  
LEBEL M, 1991, EUR J CLIN MICROBIOL, P516
[8]  
LEIBOVICI L, 1991, Q J MED, V78, P43
[9]  
MACHKA C, 1984, FAC FORTSCHR ANTIMIC, V3, P557
[10]   ABSORPTION, DISTRIBUTION, METABOLIC-FATE, AND ELIMINATION OF PEFLOXACIN MESYLATE IN MICE, RATS, DOGS, MONKEYS, AND HUMANS [J].
MONTAY, G ;
GOUEFFON, Y ;
ROQUET, F .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 25 (04) :463-472